At the EGM held on October 25, the shareholders of Sopharma (SFA) approved a gross DPS of BGN 0.075 for H1’24. The total amount to be distributed stands at c. BGN 12.4m (165.7m outstanding shares). The sum corresponds to a 55.8% payout ratio and an annual dividend yield of 2.84% when accounting for the BGN 0.09 dividend voted in June. The shareholders also approved a new buyback procedure under the following conditions: not more than 3% of the capital per calendar year at a minimum price per share of BGN 1.00 and a maximum price per share of BGN 7.00 with 18 months term of the procedure. Ex-dividend date is 7 November, 2024.